Cochrane Review Group
Hepato-Biliary
132 systematic reviews in Hepato-Biliary ask 1,521 questions. 19.9% have no studies to answer them, 57.6% rest on very low certainty evidence and 5.7% reach moderate or high certainty.
Reviews
132
Questions
1,521
current versions
No studies
19.9%
Moderate or high
5.7%
No studies 303 · 19.9%Ungraded 39 · 2.6%Very low 876 · 57.6%Low 216 · 14.2%Moderate 65 · 4.3%High 22 · 1.4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Microwave coagulation vs conventional surgery Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Microwave coagulation vs conventional surgery Failure to clear liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Recurrence of liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs radiofrequency ablation All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | RR 0.62 [0.26, 1.47] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Time to mortality (overall survival) · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | HR 0.63 [0.23, 1.73] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs radiofrequency ablation Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | RR 0.19 [0.01, 3.67] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone Time to mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 132
Microwave coagulation for liver metastases
CochraneSoF table
22 questions
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome
CochraneSoF table
7 questions
Modified dietary fat intake for treatment of gallstone disease in people of any age
CochraneSoF table
3 questions
Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure
CochraneSoF table
10 questions
Gene therapy for people with hepatocellular carcinoma
CochraneSoF table
30 questions
Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction
CochraneSoF table
16 questions
Antibiotic prophylaxis for leptospirosis
CochraneSoF table
14 questions
Antibiotics for treatment of leptospirosis
CochraneSoF table
12 questions
Prostaglandins for adult liver transplanted recipients
CochraneSoF table
7 questions
Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection
CochraneSoF table
10 questions
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
CochraneSoF table
20 questions
Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis
CochraneSoF table
12 questions
Exercise interventions for adults after liver transplantation
CochraneSoF table
6 questions
Granulocyte colony‐stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease
CochraneSoF table
5 questions
Antivirals for prevention of hepatitis B virus mother‐to‐child transmission in human immunodeficiency virus positive pregnant women co‐infected with hepatitis B virus
CochraneSoF table
5 questions
Machine perfusion in liver transplantation
CochraneSoF table
16 questions
Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
CochraneSoF table
2 questions
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
CochraneSoF table
2 questions
Intraperitoneal local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy
CochraneSoF table
7 questions
Electrocoagulation for liver metastases
CochraneSoF table
10 questions
Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
CochraneSoF table
5 questions
Vitamin D supplementation for chronic liver diseases in adults
CochraneSoF table
7 questions
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma
CochraneSoF table
9 questions
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis
CochraneSoF table
34 questions
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis
CochraneSoF table
40 questions